These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


226 related items for PubMed ID: 17724726

  • 1. Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia.
    Baz R, Rodriguez C, Fu AZ, Jawde RA, Kalaycio M, Advani A, Sobecks R, Sekeres MA.
    Cancer; 2007 Oct 15; 110(8):1752-9. PubMed ID: 17724726
    [Abstract] [Full Text] [Related]

  • 2. Disease biology rather than age is the most important determinant of survival of patients > or = 60 years with acute myeloid leukemia treated with uniform intensive therapy.
    Gupta V, Chun K, Yi QL, Minden M, Schuh A, Wells R, Brandwein J.
    Cancer; 2005 May 15; 103(10):2082-90. PubMed ID: 15830348
    [Abstract] [Full Text] [Related]

  • 3. Long-term survival of patients with acute myeloid leukemia: a third follow-up of the Fourth International Workshop on Chromosomes in Leukemia.
    Bloomfield CD, Shuma C, Regal L, Philip PP, Hossfeld DK, Hagemeijer AM, Garson OM, Peterson BA, Sakurai M, Alimena G, Berger R, Rowley JD, Ruutu T, Mitelman F, Dewald GW, Swansbury J.
    Cancer; 1997 Dec 01; 80(11 Suppl):2191-8. PubMed ID: 9395033
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia.
    Etienne A, Esterni B, Charbonnier A, Mozziconacci MJ, Arnoulet C, Coso D, Puig B, Gastaut JA, Maraninchi D, Vey N.
    Cancer; 2007 Apr 01; 109(7):1376-83. PubMed ID: 17326052
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
    Niparuck P, Chuncharunee S, Ungkanont A, Udomtrupayakul U, Aungchaisuksiri P, Rerkamnuatchoke B, Jootar S, Atichartakarn V.
    J Med Assoc Thai; 2009 Sep 01; 92(9):1143-9. PubMed ID: 19772172
    [Abstract] [Full Text] [Related]

  • 8. Aggressive salvage treatment is not appropriate for the majority of elderly patients with acute myeloid leukemia relapsed from first complete remission.
    Ferrara F, Morabito F, Latagliata R, Martino B, Annunziata M, Oliva E, Schiavone EM, Pollio F, Palmieri S, Gianfaldoni G, Leoni F.
    Haematologica; 2001 Aug 01; 86(8):814-20. PubMed ID: 11522537
    [Abstract] [Full Text] [Related]

  • 9. Acute myeloid leukemia treatment in patients over 60 years of age. Comparison of symptomatic, palliative, and aggressive therapy.
    Doubek M, Palasek I, Brychtova Y, Buchtova I, Mayer J.
    Neoplasma; 2005 Aug 01; 52(5):411-4. PubMed ID: 16151586
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.
    Koh Y, Park J, Ahn KS, Kim I, Bang SM, Lee JH, Yoon SS, Soon Lee D, Yiul Lee Y, Park S, Kim BK.
    Ann Hematol; 2009 Nov 01; 88(11):1089-97. PubMed ID: 19296110
    [Abstract] [Full Text] [Related]

  • 12. The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups.
    Schoch C, Kern W, Schnittger S, Büchner T, Hiddemann W, Haferlach T.
    Haematologica; 2004 Sep 01; 89(9):1082-90. PubMed ID: 15377469
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Prognostic factor analysis of 77 old patients with acute myelogenous leukemia].
    Shao B, Gao YR, Wang C, Yan SK, Cai Q, Jiang JL, Yang J, Bai HT, Zhao M, Zhao CX.
    Ai Zheng; 2006 Aug 01; 25(8):1007-12. PubMed ID: 16965684
    [Abstract] [Full Text] [Related]

  • 16. Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia.
    Roboz GJ, Ritchie EK, Curcio T, Provenzano J, Carlin R, Samuel M, Wittenberg B, Mazumdar M, Christos PJ, Mathew S, Allen-Bard S, Feldman EJ.
    Cancer; 2008 Nov 01; 113(9):2504-11. PubMed ID: 18825661
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup.
    Prébet T, Boissel N, Reutenauer S, Thomas X, Delaunay J, Cahn JY, Pigneux A, Quesnel B, Witz F, Thépot S, Ugo V, Terre C, Recher C, Tavernier E, Hunault M, Esterni B, Castaigne S, Guilhot F, Dombret H, Vey N, Acute Leukemia French Association, Groupe Ouest-Est des leucémies et autres maladies du sang (GOELAMS), Core Binding Factor Acute Myeloid Leukemia (CBF AML) intergroup.
    J Clin Oncol; 2009 Oct 01; 27(28):4747-53. PubMed ID: 19720919
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The benefit of induction chemotherapy in patients age > or = 75 years.
    Vey N, Coso D, Bardou VJ, Stoppa AM, Braud AC, Bouabdallah R, Sainty D, Mozziconacci MJ, Lafage M, Damaj G, Blaise D, Gastaut JA, Maraninchi D.
    Cancer; 2004 Jul 15; 101(2):325-31. PubMed ID: 15241830
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.